HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kristl Vonck Selected Research

Vagus Nerve Stimulation

4/2022Laryngeal Muscle-Evoked Potential Recording as an Indicator of Vagal Nerve Fiber Activation.
1/2022The potential of invasive and non-invasive vagus nerve stimulation to improve verbal memory performance in epilepsy patients.
1/2022Investigating the Effect of Transcutaneous Auricular Vagus Nerve Stimulation on Cortical Excitability in Healthy Males.
1/2022Transcutaneous auricular vagus nerve stimulation cannot modulate the P3b event-related potential in healthy volunteers.
11/2021Feasibility of transcutaneous auricular vagus nerve stimulation in treatment of drug resistant epilepsy: A multicenter prospective study.
10/2021Non-invasive vagal nerve stimulation enhances cognitive emotion regulation.
3/2021Pre-ictal heart rate variability alterations in focal onset seizures and response to vagus nerve stimulation.
1/2020Transcutaneous Vagus Nerve Stimulation Does Not Affect Verbal Memory Performance in Healthy Volunteers.
11/2019Hypothermia Masks Most of the Effects of Rapid Cycling VNS on Rat Hippocampal Electrophysiology.
9/2019Vagus nerve stimulation in refractory and super-refractory status epilepticus - A systematic review.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kristl Vonck Research Topics

Disease

37Drug Resistant Epilepsy
04/2022 - 04/2002
36Epilepsy (Aura)
01/2022 - 09/2003
20Temporal Lobe Epilepsy
01/2022 - 11/2002
19Seizures (Absence Seizure)
01/2022 - 11/2002
4Status Epilepticus (Complex Partial Status Epilepticus)
01/2022 - 05/2009
2Hypothermia
11/2019 - 08/2017
2Heart Failure
01/2018 - 08/2017
2Soft Tissue Infections
01/2017 - 06/2014
2Partial Epilepsies (Epilepsy, Partial)
01/2017 - 06/2014
2Disease Progression
11/2015 - 06/2006
2Absence Epilepsy (Childhood Absence Epilepsy)
01/2005 - 04/2004
1Cognitive Dysfunction
01/2022
1Major Depressive Disorder (Major Depressive Disorders)
10/2021
1Neoplasms (Cancer)
09/2020
1Stroke (Strokes)
01/2020
1Cerebral Hemorrhage
01/2020
1Hemorrhage
01/2020
1Rheumatoid Arthritis
01/2018
1Pain (Aches)
08/2017
1Alzheimer Disease (Alzheimer's Disease)
08/2017
1Tinnitus
08/2017
1Seroma
01/2016
1Dysphonia (Spastic Dysphonia)
11/2015
1Anhedonia
01/2015
1Mental Disorders (Mental Disorder)
01/2015
1Wounds and Injuries (Trauma)
09/2011
1Nervous System Diseases (Neurological Disorders)
08/2010
1Coma (Comas)
05/2009
1Weight Loss (Weight Reduction)
09/2008
1Intracranial Hemorrhages (Intracranial Hemorrhage)
08/2007
1Parkinsonian Disorders (Parkinsonism)
12/2006
1Multiple System Atrophy
04/2006
1Infantile Spasms (West Syndrome)
09/2005
1Enterocolitis
03/2004

Drug/Important Bio-Agent (IBA)

8Kainic Acid (Kainate)IBA
01/2022 - 09/2010
6Pharmaceutical PreparationsIBA
01/2022 - 12/2005
6Anticonvulsants (Antiepileptic Drugs)IBA
11/2019 - 06/2006
5Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2011
4Levetiracetam (Keppra)FDA LinkGeneric
01/2022 - 03/2004
3Clozapine (Clozaril)FDA LinkGeneric
01/2022 - 11/2019
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 05/2011
3Adenosine (Adenocard)FDA LinkGeneric
06/2011 - 06/2010
2salicylhydroxamic acid (SHAM)IBA
01/2017 - 06/2014
2Uric Acid (Urate)IBA
03/2016 - 01/2016
2Urate Oxidase (Uricase)IBA
03/2016 - 01/2016
2Pilocarpine (Ocusert)FDA LinkGeneric
01/2016 - 05/2011
2Amobarbital (Amsal)IBA
09/2005 - 02/2004
1LigandsIBA
01/2022
1JHU37160IBA
01/2022
1Designer DrugsIBA
01/2022
1Messenger RNA (mRNA)IBA
09/2020
1Tumor Biomarkers (Tumor Markers)IBA
09/2020
1Collagenases (Collagenase)FDA Link
01/2020
1Coloring Agents (Dyes)IBA
01/2020
1diazonaphthalenedisulfonic acid (NDS)IBA
01/2020
1cresyl violetIBA
01/2020
1MedetomidineIBA
11/2019
1clozapine N-oxideIBA
11/2019
1Allopurinol (Remid)FDA LinkGeneric
03/2016
1Pentylenetetrazole (Metrazol)IBA
01/2016
1EnzymesIBA
01/2016
1MTOR InhibitorsIBA
11/2015
1ChromatinIBA
11/2015
1TOR Serine-Threonine KinasesIBA
11/2015
1SaccharinIBA
01/2015
1Antidepressive Agents (Antidepressants)IBA
01/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2011
1Interleukin-6 (Interleukin 6)IBA
09/2009
1LipopolysaccharidesIBA
09/2009
1Interleukin-10 (Interleukin 10)IBA
09/2009
1Interleukin-8 (Interleukin 8)IBA
09/2009
1CytokinesIBA
09/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
09/2009
1Thiopental (Pentothal)FDA Link
05/2009
1CarbohydratesIBA
09/2008
1Lamotrigine (Lamictal)FDA LinkGeneric
12/2006
1Neuroprotective AgentsIBA
06/2006
1PlasticsIBA
06/2006
1Adrenocorticotropic Hormone (ACTH)FDA Link
09/2005
1SteroidsIBA
09/2005

Therapy/Procedure

45Vagus Nerve Stimulation
04/2022 - 04/2002
16Therapeutics
04/2022 - 02/2004
13Electrodes (Electrode)
12/2020 - 11/2002
13Deep Brain Stimulation
01/2020 - 11/2002
2Ketogenic Diet
11/2015 - 03/2014
1Aftercare (After-Treatment)
01/2022
1Stroke Rehabilitation
01/2018
1Transcranial Magnetic Stimulation
01/2016
1Drug Therapy (Chemotherapy)
01/2015
1Investigational Therapies (Experimental Therapy)
11/2010
1Cannula
09/2010
1Cell Transplantation
12/2009
1High-Protein Low-Carbohydrate Diet (Atkins Diet)
09/2008